Back

Cumulative plaque burden analysis for phenotyping epicardial coronary artery disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Seeing is believing: advances in coronary imaging Intracoronary Ultrasound ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Tsungying Tsai

University of Galway, Galway (Ireland)

5 More presentations in this session

Presentation thumbnail
Intravascular imaging-guided vs angiography-guided complex PCI in patients with high bleeding risk
Associate Professor J. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Very long-term prognostic value of SYNTAX score, intravascular ultrasound and near-infrared spectroscopy in patients with coronary artery disease: 12-year follow-up
Mr V. Meuleman (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Plaque characteristics in patients with very low low-density lipoprotein cholesterol levels not treated with statins: an intracoronary optical coherence tomography study
Associate Professor H. Amano (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Comparative effectiveness of OCT- vs. angiography-guided PCI: a meta-analysis with new evidence from RCTs
Mr S. Zreigh (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Comparison of procedural and clinical outcomes of angiography- vs. imaging-guided percutaneous coronary intervention with intravascular lithotripsy
Doctor A. Phagu (Leiden, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Seeing is believing: advances in coronary imaging

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Intracoronary imaging: from research tool to class IA in the Guidelines
thumbnail
Congress Presentation
Optical coherence tomography and intravascular ultrasound: which is the best technique in different scenarios?
thumbnail
Congress Presentation
Prognostic impact of intravascular imaging in percutaneous coronary intervention according to atherothrombotic risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources